Profile for South Korea Patent: 102239374
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for South Korea Patent: 102239374
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,287,586 | Nov 12, 2030 | Sarepta Theraps Inc | AMONDYS 45 | casimersen |
| 10,781,450 | Nov 12, 2030 | Sarepta Theraps Inc | AMONDYS 45 | casimersen |
| 9,228,187 | Nov 12, 2030 | Sarepta Theraps Inc | AMONDYS 45 | casimersen |
| 9,758,783 | Nov 12, 2030 | Sarepta Theraps Inc | AMONDYS 45 | casimersen |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
